Suppression of hepatocarcinoma model in vitro and in vivo by ECRG2 delivery using adenoviral vector

Cancer Gene Therapy

Volumn 19, Issue 12, 2012, Pages 875-879

  Song, H ^a   Song, C ^b   Wang, H ^a   Li, C ^a   Yang, F ^b   Lu, S H ^a   Lin, C ^a   Zhan, Q ^a   Wang, X ^b   Qian, H ^a  

^a CANCER HOSPITAL   (China)

^b HEBEI UNITED UNIVERSITY   (China)

Author keywords

adhesion; cancer; ECRG2; invasion

Indexed keywords

AD P 53; ADENOVIRUS VECTOR; ANTINEOPLASTIC AGENT; BETA ACTIN; CONTUSUGENE LADENOVEC; ESOPHAGEAL CANCER RELATED GENE 2; GELATINASE A; MATRIGEL; MESSENGER RNA; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; UVOMORULIN;

APOPTOSIS; ARTICLE; CANCER GENE THERAPY; CANCER INHIBITION; CANCER INVASION; CELL ADHESION; CONTROLLED STUDY; CYTOPLASM; DRUG POTENCY; FEMALE; IN VIVO STUDY; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VIRAL GENE THERAPY;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL ADHESION; CELL LINE, TUMOR; GENETIC VECTORS; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MCF-7 CELLS; MICE; PROTEINASE INHIBITORY PROTEINS, SECRETORY; SERINE PROTEINASE INHIBITORS; TRANSFECTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

ANIMALIA;

EID: 84869228289     PISSN: 09291903     EISSN: 14765500     Source Type: Journal    
DOI: 10.1038/cgt.2012.77     Document Type: Article

References (16)

1. New treatment strategy enhances outcome for lung cancer. Cancer Biol Ther 2009; 8: iv.
2. Cacheux W, Le Tourneau C, Baranger B, Mignot L, Mariani P. Targeted biotherapy in metastatic colorectal carcinoma: Current practice. J Visc Surg 2011; 148: 12-18.
3. Alvi AJ, Austen B, Weston VJ, Fegan C, MacCallum D, Gianella-Borradori A et al. A novel CDK inhibitor, CYC202 (R-roscovitine), overcomes the defect in p53-dependent apoptosis in B-CLL by down-regulation of genes involved in transcription regulation and survival. Blood 2005; 105: 4484-4491. (Pubitemid 40720798)
4. Cui Y, Wang J, Zhang X, Lang R, Bi M, Guo L et al. ECRG2, a novel candidate of tumor suppressor gene in the esophageal carcinoma, interacts directly with metallothionein 2A and links to apoptosis. Biochem Biophys Res Commun 2003; 302: 904-915. (Pubitemid 36294062)
5. Cheng X, Lu SH, Cui Y. ECRG2 regulates ECM degradation and uPAR/FPRL1 pathway contributing cell invasion/migration. Cancer Lett 2010; 290: 87-95.
6. Huang G, Hu Z, Li M, Cui Y, Li Y, Guo L et al. ECRG2 inhibits cancer cell migration, invasion and metastasis through the down-regulation of uPA/plasmin activity. Carcinogenesis 2007; 28: 2274-2281. (Pubitemid 350111585)
7. Liu Y, Li Y, Wang H, Yu J, Lin H, Xu D et al. Reduced MTA1 expression by RNAi inhibits in vitro invasion and migration of esophageal squamous cell carcinoma cell line. Clin Exp Metastasis 2005; 22: 653-662.
8. Qian H, Yu J, Li Y, Wang H, Song C, Zhang X et al. RNA interference of metastasisassociated gene 1 inhibits metastasis of B16F10 melanoma cells in a C57BL/6 mouse model. Biol Cell 2007; 99: 573-581. (Pubitemid 47543315)
9. Su T, Liu H, Lu S. Cloning and identification of cDNA fragments related to human esophageal cancer. Zhonghua Zhong Liu Za Zhi 1998; 20: 254-257.
10. Cheng X, Shen Z, Yin L, Lu SH, Cui Y. ECRG2 regulates cell migration/invasion through urokinase-type plasmin activator receptor (uPAR)/beta1 integrin pathway. J Biol Chem 2009; 284: 30897-30906.
11. Cheng X, Shen Z, Yang J, Lu SH, Cui Y. ECRG2 disruption leads to centrosome amplification and spindle checkpoint defects contributing chromosome instability. J Biol Chem 2008; 283: 5888-5898.
12. Blessmann M, Kaifi JT, Schurr PG, Cihan A, Kalinin V, Trump F et al. Short tandem repeat polymorphism in exon 4 of esophageal cancer related gene 2 predicts relapse of oral squamous cell carcinoma. Oral Oncol 2008; 44: 143-147. (Pubitemid 351179657)
13. Kaifi JT, Cataldegirmen G, Wachowiak R, Schurr PG, Kleinhans H, Kosti G et al. Short tandem repeat polymorphisms of exon 4 in Kazal-type gene ECRG2 in pancreatic carcinoma and chronic pancreatitis. Anticancer Res 2007; 27: 69-73.
14. Yue C, Bi M, Tan W, Deng D, Zhang X, Guo L et al. Short tandem repeat polymorphism in a novel esophageal cancer-related gene (ECRG2) implicates susceptibility to esophageal cancer in Chinese population. Int J Cancer 2004; 108: 232-236. (Pubitemid 37541776)
15. Beg AA, Baldwin Jr. AS. The I kappa B proteins: multifunctional regulators of Rel/NF-kappa B transcription factors. Genes Dev 1993; 7: 2064-2070.
16. Han SW, Roman J. Fibronectin induces cell proliferation and inhibits apoptosis in human bronchial epithelial cells: pro-oncogenic effects mediated by PI3-kinase and NF-kappa B. Oncogene 2006; 25: 4341-4349. (Pubitemid 44100504)